RA in Remission? Stopping DMARDs May Be OK
(MedPage Today) -- Most rheumatoid arthritis (RA) patients who maintained remission with half-doses of conventional disease-modifying anti-rheumatic drug (DMARD) therapy and then proceeded to full stoppage stayed flare-free for 1 year, results... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - March 28, 2023 Category: Rheumatology Source Type: news
Peninsula cell therapy company lands big deal with Regeneron
While most cell therapy companies target cancer, Sonoma Bio is hitting autoimmune and inflammatory diseases, including rheumatoid arthritis, ulcerative colitis and more. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - March 28, 2023 Category: American Health Authors: Ron Leuty Source Type: news
FDA Approves New Formulation of Hyrimoz Adalimumab Biosimilar FDA Approves New Formulation of Hyrimoz Adalimumab Biosimilar
The agency approved a higher concentration formulation of Hyrimoz for its previous indications, including rheumatoid arthritis and psoriasis.Medscape Medical News (Source: Medscape Pediatrics Headlines)
Source: Medscape Pediatrics Headlines - March 27, 2023 Category: Pediatrics Tags: Rheumatology News Alert Source Type: news
Improved Outcomes in RA With Obesity After Weight Loss Improved Outcomes in RA With Obesity After Weight Loss
In this study, obese rheumatoid arthritis patients who successfully lost weight with a targeted diet and exercise intervention realized improved outcomes.Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 27, 2023 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news
Prevalence and risk factors of falls in adults with rheumatoid arthritis: a systematic review and meta-analysis - Guo X, Pei J, Wei Y, Zhang G, Yan F, Han L.
BACKGROUND: Despite the fact that the estimated prevalence and risk factors of falls in adults with rheumatoid arthritis (RA) are widely reported, these results have not been synthesized. The systematic review and meta-analysis aimed to investigate the pre... (Source: SafetyLit)
Source: SafetyLit - March 25, 2023 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news
Tofacitinib May Reduce Risk of Interstitial Lung Disease in RA Patients
(MedPage Today) -- Tofacitinib (Xeljanz) in patients with rheumatoid arthritis (RA) stood out among several other biologic and targeted synthetic disease-modifying antirheumatic drugs (sDMARDs) when it came to the incidence of interstitial lung... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - March 21, 2023 Category: Rheumatology Source Type: news
Dermatology Risks Are Likely Different for JAK Inhibitors Dermatology Risks Are Likely Different for JAK Inhibitors
Black box warnings for JAK inhibitors arise from rheumatoid arthritis studies, leading one expert to question the risk-benefit relevance to dermatologic diseases, particularly in younger patients.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 19, 2023 Category: Consumer Health News Tags: Dermatology News Source Type: news
Artificial sweetener might ease symptoms of rheumatoid arthritis - new research
Artificial sweeteners have the potential to suppress the immune system that otherwise attacks healthy joints in rheumatoid arthritis patients. (Source: Daily Express - Health)
Source: Daily Express - Health - March 16, 2023 Category: Consumer Health News Source Type: news
Association of rheumatoid arthritis with opioid pain medication overuse among persons exposed to the 9/11 World Trade Center Disaster - Dhanya AS, Yung J, Cone JE, Li J.
We examined the association of post-9/11 rheumatoid arthritis (RA) diagnosis with opioid pain medication overuse among enrollees in the World Trade Center Health Registry (WTCHR). Opioid overuse was defined as the self-reported intake of prescribed opioids... (Source: SafetyLit)
Source: SafetyLit - March 15, 2023 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Cancer, biosimilar drug maker Coherus shedding more biotech jobs
Coherus is expected to launch a biosimilar of the rheumatoid arthritis drug Humira and recently won FDA approval of its autoinjector product for cancer patients with anemia. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - March 10, 2023 Category: American Health Authors: Ron Leuty Source Type: news
Genetic variation that protected against Black Death still helps protect against infection but increases autoimmune disease
The same genetics that helped some of our ancestors fight the plague is still likely to be at work in our bodies today, potentially providing some of the population with extra protection against respiratory diseases such as COVID-19, according to research led by scientists at University of Bristol. However, there is a trade-off, where this same variation is also linked to increased autoimmune diseases such as rheumatoid arthritis and inflammatory bowel disease. (Source: University of Bristol news)
Source: University of Bristol news - March 7, 2023 Category: Universities & Medical Training Tags: Health, Research, International; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School, Faculty of Health Sciences, Population Health Sciences, Institutes, Institutes, Bristol Population Health Science Institute; Press Release Source Type: news
Four signs of rheumatoid arthritis not related to the joints - 'stop disease progression'
Arthritis isn't always the result of wear and tear over time; sometimes, the condition is an inflammatory autoimmune response. (Source: Daily Express - Health)
Source: Daily Express - Health - March 1, 2023 Category: Consumer Health News Source Type: news
Yale expands Cardio-Rheumatology Program
The program provides personalized cardiovascular risk assessment and treatment for patients with autoimmune diseases, including rheumatoid arthritis. (Source: Yale Science and Health News)
Source: Yale Science and Health News - February 28, 2023 Category: Universities & Medical Training Source Type: news
Digital twin opens way to effective treatment of inflammatory diseases
Inflammatory diseases like rheumatoid arthritis have complex disease mechanisms that can differ from patient to patient with the same diagnosis. This means that currently available drugs have little effect on many patients. Using so-called digital twins, researchers at Karolinska Institutet have now obtained a deeper understanding of the “off and on” proteins that control these diseases. (Source: World Pharma News)
Source: World Pharma News - February 28, 2023 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Bacteremia, Antibodies Link Periodontal Disease and RA Bacteremia, Antibodies Link Periodontal Disease and RA
Periodontal disease may introduce bacteria into the bloodstream that trigger immune responses in patients with rheumatoid arthritis, new research suggests.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 27, 2023 Category: Consumer Health News Tags: Rheumatology News Source Type: news
